These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11154979)

  • 1. The cellular immune system of patients with acute leukemia and severe chemotherapy-induced leukopenia: characterization of T lymphocyte subsets responsive to IL-16 and IL-17.
    Bruserud O; von Volkman HL; Ulvestad E
    Acta Haematol; 2000; 104(2-3):80-91. PubMed ID: 11154979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia.
    Bruserud O; Ulvestad E
    J Interferon Cytokine Res; 2000 Nov; 20(11):947-54. PubMed ID: 11096451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells.
    Bruserud O
    Cancer Immunol Immunother; 1998 Jun; 46(4):221-8. PubMed ID: 9671145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia.
    Wendelbo Ø; Nesthus I; Sjo M; Paulsen K; Ernst P; Bruserud Ø
    Cancer Immunol Immunother; 2004 Aug; 53(8):740-7. PubMed ID: 15133630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-lymphocyte functions in acute leukaemia patients with severe chemotherapy-induced cytopenia: characterization of clonogenic T-cell proliferation.
    Bruserud O; Ulvestad E; Berentsen S; Bergheim J; Nesthus I
    Scand J Immunol; 1998 Jan; 47(1):54-62. PubMed ID: 9467659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of imipenem and cilastatin on human T-lymphocytes derived from acute leukemia patients with chemotherapy-induced leucopenia: studies of T-lymphocyte responses in the presence of acute myelogenous leukemia (AML) blast accessory cells.
    Bruserud O
    Int J Immunopharmacol; 2000 Jan; 22(1):69-81. PubMed ID: 10684990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
    Bruserud O; Ulvestad E
    Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cells.
    Bruserud O; Ulvestad E
    Cancer Immunol Immunother; 2003 Apr; 52(4):215-25. PubMed ID: 12669246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-7 (IL-7) in patients receiving intensive chemotherapy for acute myelogenous leukemia: studies of systemic IL-7 Levels and IL-7 responsiveness of circulating T lymphocytes.
    Wendelbo Ø; Glenjen N; Bruserud Ø
    J Interferon Cytokine Res; 2002 Oct; 22(10):1057-65. PubMed ID: 12433286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopenia.
    Bruserud O; Ulvestad E; Halstensen A; Berentsen S; Bergheim J; Nesthus I
    Eur J Haematol; 1997 Nov; 59(5):269-76. PubMed ID: 9414637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells.
    Levine BL; Bernstein WB; Connors M; Craighead N; Lindsten T; Thompson CB; June CH
    J Immunol; 1997 Dec; 159(12):5921-30. PubMed ID: 9550389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of shenqi fuzheng injection combined with chemotherapy in treatment of acute leukemia and its effect on T-lymphocyte subsets, serum IFN-gamma, IL-10 and IL-2].
    Wei YF; Wang SY; Ren LL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Apr; 25(4):303-6. PubMed ID: 15892271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
    Yoshizawa H; Chang AE; Shu SY
    Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipients.
    Lum LG; Joshi ID; Galoforo SC; Abella E; Karanes C; Ratanatharathorn V; Schultz KR; Uberti JP; Sensenbrenner LL; Ledbetter JA
    Bone Marrow Transplant; 1993 Dec; 12(6):565-71. PubMed ID: 8136739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.
    Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA
    J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human atopen-specific types 1 and 2 T helper cell clones.
    Wierenga EA; Snoek M; Jansen HM; Bos JD; van Lier RA; Kapsenberg ML
    J Immunol; 1991 Nov; 147(9):2942-9. PubMed ID: 1680923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-2-induced IL-9 production by allergen-specific human helper T-cell clones.
    Kajiyama Y; Umezu-Goto M; Kobayashi N; Takahashi K; Fukuchi Y; Mori A
    Int Arch Allergy Immunol; 2007; 143 Suppl 1():71-5. PubMed ID: 17541281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.